Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Open Access
- 1 April 2016
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (4) , 771-775
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Safety and Immunogenicity of the Live Attenuated Varicella Vaccine Following T Replete or T Cell-Depleted Related and Unrelated Allogeneic Hematopoietic Cell Transplantation (alloHCT)Transplantation and Cellular Therapy, 2011
- Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantationBritish Journal of Haematology, 2011
- Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTsBone Marrow Transplantation, 2010
- Vaccination of hematopoietic cell transplant recipientsBone Marrow Transplantation, 2009
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global PerspectiveTransplantation and Cellular Therapy, 2009
- Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMTBone Marrow Transplantation, 2005
- Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplantsBone Marrow Transplantation, 2004
- Varicella vaccination in children after bone marrow transplantationBone Marrow Transplantation, 1997
- LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITALThe Lancet, 1974